[Myocardial remodeling in pediatric congenital cardiac diseases]
Insights
Pediatric congenital heart disease causes myocardial remodeling via inflammation and stress signaling. Hypoxemia in these infants may impair protective growth signals, increasing cardiac dysfunction.
Area of Science:
- Cardiology
- Molecular Biology
- Pediatrics
Background:
- Myocardial remodeling in pediatric congenital heart diseases contributes to dysfunction, morbidity, and mortality.
- This remodeling involves complex inflammatory, growth, and cell death signaling pathways.
Purpose of the Study:
- To investigate the molecular mechanisms of myocardial remodeling in infants with right ventricular pressure overload and hypoxemia.
- To elucidate the roles of specific signaling pathways, including p38MAPK, HIF-1, and JAK/STAT, in response to hemodynamic stress and hypoxemia.
Main Methods:
- Analysis of myocardial tissue and signaling pathways in infants with right ventricular pressure overload.
- Assessment of pro-inflammatory cytokine expression (TNF-α, IL-1β, IL-6) and activation of p38MAPK signaling.
- Evaluation of hypoxia-inducible factor 1 (HIF-1) activation and its downstream targets (VEGF, eNOS) and growth signaling (CT-1) via JAK/STAT pathway.
Main Results:
- Right ventricular pressure overload induces pro-inflammatory cytokine expression via p38MAPK activation.
- Hypoxemia activates HIF-1, leading to VEGF and eNOS induction, potentially as an adaptive response.
- Hypoxemia also stimulates CT-1 via JAK/STAT, but increased troponin T degradation suggests impaired protective function in cyanotic infants.
Conclusions:
- Mechanical stress and hypoxemia differentially regulate inflammatory and growth signaling in pediatric congenital heart disease.
- Hypoxemia's dual role in potentially adaptive responses and impaired myocardial protection warrants further investigation.
- Understanding these pathways is crucial for managing myocardial remodeling and improving outcomes in affected children.
Abstract:
Myocardial remodeling in pediatric congenital cardiac diseases is related to myocardial dysfunction and increases morbidity and mortality. The complex mechanisms that characterize this state involve inflammatory-, growth- and death signaling. The studies we have conducted in infants with hemodynamic overload of the right ventricle, associated or not with hypoxemia, show that mechanical stress related to pressure overload of the right ventricle leads to myocardial expression of pro-inflammatory cytokines such as TNF-α, IL-1β et IL-6, mainly via the activation of p38MAPK signaling. Furthermore, hypoxemia induces activation of the transcription factor HIF-1 that, in turn, induces its target genes VEGF and eNOS. This might be interpreted as an adaptive response. Hypoxemia also contributes to stimulation of growth signaling as it induces CT-1 via the JAK/STAT pathway. The observation that hypoxemia is also associated with a higher degree of troponin T degradation might indicate a loss of the protective function of CT-1 to the myocardium in infants with cyanotic congenital cardiac diseases.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Heart Failure II: Pathophysiology
Cardiomyopathy IV: Restrictive Cardiomyopathy


